Buy IBIO by Oct 21, 2026.

Ticker: $IBIO - iBio Inc Price: \~$1.35 | Market Cap: \~$70M | 52W: $0.56 - $3.82 TLDR: 7.78% of float short, DTC 4.8 days, short interest +10.31% MoM. Interesting micro-cap setup, but NOT a squeeze yet. High risk biotech. 1. What is it? iBio is a pre-clinical AI biotech focused on obesity / cardiometabolic + AI antibody discovery. No commercial products, no revenue, burns cash like every micro-biotech. 2. Hard Data (MarketBeat / FINRA - May 29, 2026): \- Short …